These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 25833959)

  • 1. Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling.
    Yeh YY; Ozer HG; Lehman AM; Maddocks K; Yu L; Johnson AJ; Byrd JC
    Blood; 2015 May; 125(21):3297-305. PubMed ID: 25833959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p.
    Farahani M; Rubbi C; Liu L; Slupsky JR; Kalakonda N
    PLoS One; 2015; 10(10):e0141429. PubMed ID: 26509439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
    Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
    Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
    Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
    Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
    Sharma S; Pavlasova GM; Seda V; Cerna KA; Vojackova E; Filip D; Ondrisova L; Sandova V; Kostalova L; Zeni PF; Borsky M; Oppelt J; Liskova K; Kren L; Janikova A; Pospisilova S; Fernandes SM; Shehata M; Rassenti LZ; Jaeger U; Doubek M; Davids MS; Brown JR; Mayer J; Kipps TJ; Mraz M
    Blood; 2021 May; 137(18):2481-2494. PubMed ID: 33171493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression.
    Pede V; Rombout A; Vermeire J; Naessens E; Mestdagh P; Robberecht N; Vanderstraeten H; Van Roy N; Vandesompele J; Speleman F; Philippé J; Verhasselt B
    PLoS One; 2013; 8(4):e60275. PubMed ID: 23560086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
    Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
    Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes derived from chronic lymphocytic leukaemia cells transfer miR-146a to induce the transition of mesenchymal stromal cells into cancer-associated fibroblasts.
    Yang Y; Li J; Geng Y
    J Biochem; 2020 Nov; 168(5):491-498. PubMed ID: 32770182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
    Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
    Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
    Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell receptor signaling in chronic lymphocytic leukemia.
    Burger JA; Chiorazzi N
    Trends Immunol; 2013 Dec; 34(12):592-601. PubMed ID: 23928062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
    Paggetti J; Haderk F; Seiffert M; Janji B; Distler U; Ammerlaan W; Kim YJ; Adam J; Lichter P; Solary E; Berchem G; Moussay E
    Blood; 2015 Aug; 126(9):1106-17. PubMed ID: 26100252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells.
    Cerna K; Oppelt J; Chochola V; Musilova K; Seda V; Pavlasova G; Radova L; Arigoni M; Calogero RA; Benes V; Trbusek M; Brychtova Y; Doubek M; Mayer J; Pospisilova S; Mraz M
    Leukemia; 2019 Feb; 33(2):403-414. PubMed ID: 30111844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
    Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
    Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotyped B-cell receptors in chronic lymphocytic leukemia.
    Agathangelidis A; Vardi A; Baliakas P; Stamatopoulos K
    Leuk Lymphoma; 2014 Oct; 55(10):2252-61. PubMed ID: 24397617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.
    Ntoufa S; Papakonstantinou N; Apollonio B; Gounari M; Galigalidou C; Fonte E; Anagnostopoulos A; Belessi C; Muzio M; Ghia P; Stamatopoulos K
    J Immunol; 2016 May; 196(10):4410-7. PubMed ID: 27059597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
    Ten Hacken E; Sivina M; Kim E; O'Brien S; Wierda WG; Ferrajoli A; Estrov Z; Keating MJ; Oellerich T; Scielzo C; Ghia P; Caligaris-Cappio F; Burger JA
    J Immunol; 2016 Sep; 197(6):2522-31. PubMed ID: 27534555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia.
    Mraz M; Kipps TJ
    Leuk Lymphoma; 2013 Aug; 54(8):1836-9. PubMed ID: 23597135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia.
    Papakonstantinou N; Ntoufa S; Chartomatsidou E; Papadopoulos G; Hatzigeorgiou A; Anagnostopoulos A; Chlichlia K; Ghia P; Muzio M; Belessi C; Stamatopoulos K
    Mol Med; 2013 May; 19(1):115-23. PubMed ID: 23615967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
    Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
    Front Immunol; 2018; 9():1996. PubMed ID: 30271400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.